HOME Top Market Reports Molecular Diagnostics Market by Application (Infectious Disease (HIV, HBV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Hybridization, DNA Sequencing), End User (Hospitals, Laboratory), Product & Service (Reagent, Software) - Forecast to 2021

Molecular Diagnostics Market by Application (Infectious Disease (HIV, HBV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Hybridization, DNA Sequencing), End User (Hospitals, Laboratory), Product & Service (Reagent, Software) - Forecast to 2021

By: marketsandmarkets.com
Publishing Date: February 2017
Report Code: MD 2521

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global molecular diagnostics market is projected to reach USD 10.12 Billion by 2021 from USD 6.54 Billion in 2016, at a CAGR of 9.1% from 2016 to 2021. In this report, the market is broadly segmented on the basis of technology, applications, products & services, end user, and region.

The market, by application, is classified into infectious diseases, oncology, genetic tests, blood screening, microbiology, and other applications (cardiovascular diseases, neurological diseases, DNA fingerprinting, tissue typing, and food pathogen detection testing). The infectious diseases segment accounts for the largest share of the global market in 2016. This large share is attributed to the development of advanced new assays for different diseases and conditions, unprecedented occurrences of infections, and rising awareness about the use of molecular diagnostics technologies/products to control diseases.

On the basis of products and services, the market is segmented into reagents & kits, instruments, and services & software. The reagents & kits market is expected to grow at the highest CAGR of the market in the forecast period. Growth in the reagents & kits segment is driven by advancements, such as automation and high-throughput technologies in instruments.

Based on technology the market is segmented into PCR, INAAT, microarrays, hybridization, DNA sequencing, Next-generation sequencing (NGS) and other technologies (electrophoresis, flow cytometry, and mass spectrometry). Among these technologies, PCR is expected to command the largest share and microarray is expected to be the highest growing segment. The large share of this segment is primarily attributed to the growing use of PCR in proteomics & genomics, automation of PCR instruments, and emergence of advanced technologies like qRT-PCR.

By end user, the market is subsegmented into hospital & academic laboratories, reference laboratories, and other end users (blood banks, local public health laboratories, home health agencies, nursing homes, point-of-care settings, and self-testing). As most diagnostic tests are performed in-house, the hospital & academic laboratories segment is expected to dominate the market. On the other hand, newly launched, complex, and highly specialized tests are offered only at a few large reference laboratories. Hence, the segment will grow at the fastest pace.

Based on region, North America (comprising the U.S. and Canada) is expected to account for the largest share of the global molecular diagnostics market in 2016, followed by Europe. The largest share of the North American market is majorly driven by the rising prevalence of infectious diseases, availability of government funds, and expansion of the applications of molecular diagnostics in genetic disorders and cancer screening. The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. The growth in this regional segment can primarily be attributed to the presence of growing markets such as Japan, China, India, and Australia.

The major factors driving this market are the high prevalence of infectious diseases and various types of cancer, the increasing awareness and acceptance of personalized medicine and companion diagnostics, the growth in the biomarker identification market and advancements in molecular techniques; and the reforms in the reimbursement system in the U.S. However, the complex regulatory framework is the major factor restraining the growth of the market.

Major players operating in the molecular diagnostics market are Roche Diagnostics (U.S.), QIAGEN N.V. (Netherlands), Hologic Inc. (U.S.), Grifols (Spain), Abbott Laboratories (U.S.), Siemens Healthcare (Germany), Becton, Dickinson and Company (U.S.), Beckman Coulter Inc. (U.S.), bioMιrieux SA (France), and Cepheid Inc. (U.S.).

Stakeholders

  • Manufacturers and distributors of molecular diagnostic instruments & assays
  • In vitro diagnostic (IVD) companies
  • Hospital laboratories
  • Reference laboratories
  • Pharmaceutical and biotechnology companies
  • Research and consulting firms
  • Health insurance players

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

  • The market study doesn’t cover the market size in terms of volume for all MDx test
  • Company developments not reported in the public domain are not included in this report

Years considered for the study


Particular

Scope

Region

  • North America
  • Europe
  • Asia-Pacific
  • RoW

Historical Years

2014

Base Year

2015

Estimated Year

2016-e

Forecast Period

2016-e–2021-p

Revenue Currency

USD ($)

Market Segmentation

This research report categorizes the molecular diagnostics market by technology, products & services, application, end user, and region.

Molecular Diagnostics Market, by Products & Services

  • Instruments
  • Reagents & Kits
  • Services & Software

Molecular Diagnostics Market, by Technology

  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Hybridization [In Situ Hybridization & Fluorescent In Situ Hybridization (FISH)]
  • DNA Sequencing and Next-generation Sequencing
  • Microarray
  • Other Technologies (Mass Spectrometry, Flow Cytometry, and Electrophoresis)

Molecular Diagnostics Market, by Application

  • Infectious Diseases
  • Oncology
  • Genetic Tests
  • Blood Screening
  • Microbiology
  • Other Applications (Cardiovascular Diseases, Neurological Diseases, and DNA Fingerprinting)

Molecular Diagnostics Market, by End User

  • Reference Laboratories
  • Hospital/Academic Laboratories
  • Other end users (Blood Banks, Local Public Health Laboratories, Home Health Agencies, Nursing Homes, Point-of-care Settings, and Self-testing)

Molecular Diagnostics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Rest of the World (RoW)
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America (RoLA)
    • The Middle East & Africa

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographical Analysis

  • Further breakdown of the APAC market for molecular diagnostics into Rest of Asia-Pacific
  • Further breakdown of the European market molecular diagnostics into Rest of Europe

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 19)
    1.1 Objectives of the Study
    1.2 Molecular Diagnostics Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Molecular Diagnostics Market, By Region
           1.3.3 Years Considered for the Study
    1.4 Currency
    1.5 Stakeholders

2 Research Methodology (Page No. - 23)

    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
           2.2.1 Key Data From Secondary Sources
           2.2.2 Key Data From Primary Sources
                    2.2.2.1 Key Industry Insights
           2.2.3 Assumptions

3 Executive Summary (Page No. - 31)

    3.1 Introduction
    3.2 Conclusion

4 Premium Insights (Page No. - 36)

    4.1 Molecular Diagnostics: Market Overview
    4.2 Molecular Diagnostics Market Size, By Type of Infectious Disease, 2016 vs 2021
    4.3 Market, By Technology and Application
    4.4 Market Size, By End User, 2016 vs 2021
    4.5 Market Size, By Product and Service, 2016 vs 2021
    4.6 Geographic Growth Opportunities

5 Molecular Diagnostics Market Overview (Page No. - 40)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 High Prevalence of Infectious Diseases and Various Types of Cancer
                    5.2.1.2 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
                    5.2.1.3 Growth in the Biomarker Identification Market and Advancements in Molecular Techniques
                    5.2.1.4 Reforms in the Reimbursement System in the U.S.
           5.2.2 Restraints
                    5.2.2.1 Complex Regulatory Frameworks to Delay Approvals of New Molecular Diagnostic Tests
           5.2.3 Opportunities
                    5.2.3.1 Advances in Genomics and Proteomics
                    5.2.3.2 Increasing Adoption of Point-Of-Care Testing
                    5.2.3.3 Significant Growth Prospects in Developing Countries
           5.2.4 Challenge
                    5.2.4.1 Dearth of Trained Professionals Limiting the Appropriate Use of New Molecular Diagnostic Technologies

6 Molecular Diagnostics Market, By Application (Page No. - 47)
    6.1 Introduction
    6.2 Infectious Diseases
           6.2.1 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
           6.2.2 Hepatitis B
           6.2.3 Human Papillomavirus (HPV)
           6.2.4 Human Immunodeficiency Virus (HIV)
           6.2.5 Tuberculosis (TB)
           6.2.6 Hepatitis C
           6.2.7 Methicillin-Resistant Staphylococcus Aureus (MRSA)
           6.2.8 Other Infectious Diseases
    6.3 Oncology
           6.3.1 Breast Cancer
           6.3.2 Colorectal Cancer
           6.3.3 Prostate Cancer
           6.3.4 Other Cancers
    6.4 Blood Screening
    6.5 Genetic Tests
    6.6 Microbiology
    6.7 Other Applications

7 Molecular Diagnostics Market, By Technology (Page No. - 77)
    7.1 Introduction
    7.2 Polymerase Chain Reaction (PCR)
    7.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
    7.4 Hybridization (In-Situ Hybridization & Fish)
    7.5 DNA Sequencing and Next-Generation Sequencing
    7.6 Microarray
    7.7 Other Technologies

8 Molecular Diagnostics Market, By Products and Services (Page No. - 97)
    8.1 Introduction
    8.2 Reagents & Kits
    8.3 Instruments
    8.4 Software & Services

9 Molecular Diagnostics Market, By End User (Page No. - 107)
    9.1 Introduction
    9.2 Hospital and Academic Laboratories
    9.3 Reference Laboratories
    9.4 Other End Users

10 Molecular Diagnostics Market, By Region (Page No. - 118)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 France
             10.3.3 Italy
             10.3.4 Spain
             10.3.5 U.K.
             10.3.6 Rest of Europe (RoE)
     10.4 Asia-Pacific
             10.4.1 Japan
             10.4.2 China
             10.4.3 Australia
             10.4.4 India
             10.4.5 Rest of Asia-Pacific (RoAPAC)
     10.5 Rest of the World (RoW)
             10.5.1 Latin America
                        10.5.1.1 Brazil
                        10.5.1.2 Mexico
                        10.5.1.3 Rest of Latin America (ROLA)
             10.5.2 Middle East & Africa

11 Competitive Landscape (Page No. - 175)
     11.1 Overview
     11.2 Molecular Diagnostics Market Share Analysis
     11.3 Market Competitor Share Analysis, By Application
             11.3.1 Market Share Analysis for Blood Screening Applications
             11.3.2 Ranking for Microbiology Applications
     11.4 Molecular Diagnostics Market Share Analysis, By Technology
             11.4.1 Polymerase Chain Reaction (PCR)
             11.4.2 DNA Sequencing and NGs
             11.4.3 Microarray
             11.4.4 Hybridization (In Situ and Fluorescence)
             11.4.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
     11.5 New Product Launches and Approvals
     11.6 Agreements, Collaborations, Partnerships, Joint Ventures, and Contracts
     11.7 Acquisitions
     11.8 Other Strategies

12 Company Profiles (Page No. - 189)
(Overview, Products and Services, Financials, Strategy & Development)*
     12.1 Introduction
     12.2 Abbott Laboratories
     12.3 Qiagen N.V.
     12.4 Roche Diagnostics
     12.5 Hologic, Inc.
     12.6 Grifols
     12.7 Siemens Healthcare
     12.8 Becton, Dickinson and Company
     12.9 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
     12.10 Biomιrieux Sa
     12.11 Cepheid Inc.

13 Appendix (Page No. - 228)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Other Developments
     13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.5 Introducing RT: Real-Time Market Intelligence
     13.6 Available Customizations
     13.7 Related Reports
     13.8 Author Details


List of Tables (231 Tables)

Table 1 Molecular Diagnostics Market Size, By Application, 2014–2021 (USD Million)
Table 2 Infectious Disease Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 3 North America: Infectious Disease Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 4 Europe: Infectious Disease Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 5 Asia-Pacific: Infectious Disease Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 6 RoW: Infectious Disease Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 7 Latin America: Infectious Disease Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 8 Infectious Disease Diagnostics Market Size, By Therapeutic Area, 2014–2021 (USD Million)
Table 9 CT/NG Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 10 CT/NG Diagnostics Market Size, By Region, 2014–2021 (Million Assays)
Table 11 Hepatitis B Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 12 Hepatitis B Diagnostics Market Size, By Region, 2014–2021 (Million Assays)
Table 13 HPV Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 14 HPV Diagnostics Market Size, By Region, 2014–2021 (Million Assays)
Table 15 HIV Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 16 HIV Diagnostics Market Size, By Region, 2014–2021 (Million Assays)
Table 17 TB Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 18 TB Diagnostics Market Size, By Region, 2014–2021 (Million Assays)
Table 19 Hepatitis C Market Size, By Region, 2014–2021 (USD Million)
Table 20 Hepatitis C Market Size, By Region, 2014–2021 (Million Assays)
Table 21 MRSA Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 22 MRSA Diagnostics Market Size, By Region, 2014–2021 (Million Assays)
Table 23 Other Infectious Disease Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 24 Oncology Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 25 North America: Oncology Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 26 Europe: Oncology Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 27 Asia-Pacific: Oncology Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 28 RoW: Oncology Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 29 Latin America: Oncology Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 30 Oncology Diagnostics Market Size, By Type, 2014–2021 (USD Million)
Table 31 Breast Cancer Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 32 Colorectal Cancer Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 33 Prostate Cancer Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 34 Other Cancer Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 35 Blood Screening Market Size, By Region, 2014–2021 (USD Million)
Table 36 North America: Blood Screening Market Size, By Country, 2014–2021 (USD Million)
Table 37 Europe: Blood Screening Market Size, By Country, 2014–2021 (USD Million)
Table 38 Asia-Pacific: Blood Screening Market Size, By Country, 2014–2021 (USD Million)
Table 39 RoW: Blood Screening Market Size, By Region, 2014–2021 (USD Million)
Table 40 Latin America: Blood Screening Market Size, By Country, 2014–2021 (USD Million)
Table 41 Genetic Tests Market Size, By Region, 2014–2021 (USD Million)
Table 42 North America: Genetic Tests Market Size, By Country, 2014–2021 (USD Million)
Table 43 Europe: Genetic Tests Market Size, By Country, 2014–2021 (USD Million)
Table 44 Asia-Pacific: Genetic Tests Market Size, By Country, 2014–2021 (USD Million)
Table 45 RoW: Genetic Tests Market Size, By Region, 2014–2021 (USD Million)
Table 46 Latin America: Genetic Tests Market Size, By Country, 2014–2021 (USD Million)
Table 47 Microbiology Market Size, By Region, 2014–2021 (USD Million)
Table 48 North America: Microbiology Market Size, By Country, 2014–2021 (USD Million)
Table 49 Europe: Microbiology Market Size, By Country, 2014–2021 (USD Million)
Table 50 Asia-Pacific: Microbiology Market Size, By Country, 2014–2021 (USD Million)
Table 51 RoW: Microbiology Market Size, By Region, 2014–2021 (USD Million)
Table 52 Latin America: Microbiology Market Size, By Country, 2014–2021 (USD Million)
Table 53 Other Molecular Diagnostic Applications Market Size, By Region, 2014–2021 (USD Million)
Table 54 North America: Other Molecular Diagnostic Applications Market Size, By Country, 2014–2021 (USD Million)
Table 55 Europe: Other Molecular Diagnostic Applications Market Size, By Country, 2014–2021 (USD Million)
Table 56 Asia-Pacific: Other Molecular Diagnostic Applications Market Size, By Country, 2014–2021 (USD Million)
Table 57 RoW: Other Molecular Diagnostic Applications Market Size, By Region, 2014–2021 (USD Million)
Table 58 Latin America: Other Molecular Diagnostic Applications Market Size, By Country, 2014–2021 (USD Million)
Table 59 Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 60 Market Size for PCR, By Region, 2014–2021 (USD Million)
Table 61 North America: Molecular Diagnostics Market Size for PCR, By Country, 2014–2021 (USD Million)
Table 62 Europe: Market Size for PCR, By Country, 2014–2021 (USD Million)
Table 63 Asia-Pacific: Molecular Diagnostics Market Size for PCR, By Country, 2014–2021 (USD Million)
Table 64 RoW: Market Size for PCR, By Region, 2014–2021 (USD Million)
Table 65 Latin America: Molecular Diagnostics Market Size for PCR, By Country, 2014–2021 (USD Million)
Table 66 Market Size for INAAT, By Region, 2014–2021 (USD Million)
Table 67 North America: Molecular Diagnostics Market Size for INAAT, By Country, 2014–2021 (USD Million)
Table 68 Europe: Market Size for INAAT, By Country, 2014–2021 (USD Million)
Table 69 Asia-Pacific: Molecular Diagnostics Market Size for INAAT, By Country, 2014–2021 (USD Million)
Table 70 RoW: Market Size for INAAT, By Region, 2014–2021 (USD Million)
Table 71 Latin America: Molecular Diagnostics Market Size for INAAT, By Country, 2014–2021 (USD Million)
Table 72 Market Size for Hybridization, By Region, 2014–2021 (USD Million)
Table 73 North America: Molecular Diagnostics Market Size for Hybridization, By Country, 2014–2021 (USD Million)
Table 74 Europe: Market Size for Hybridization, By Country, 2014–2021 (USD Million)
Table 75 Asia-Pacific: Molecular Diagnostics Market Size for Hybridization, By Country, 2014–2021 (USD Million)
Table 76 RoW: Market Size for Hybridization, By Region, 2014–2021 (USD Million)
Table 77 Latin America: Molecular Diagnostics Market Size for Hybridization, By Country, 2014–2021 (USD Million)
Table 78 Market Size for DNA Sequencing and NGs, By Region, 2014–2021 (USD Million)
Table 79 North America: Market Size for DNA Sequencing and NGs, By Country, 2014–2021 (USD Million)
Table 80 Europe: Molecular Diagnostics Market Size for DNA Sequencing and NGs, By Country, 2014–2021 (USD Million)
Table 81 Asia-Pacific: Market Size for DNA Sequencing and NGs, By Country, 2014–2021 (USD Million)
Table 82 RoW: Molecular Diagnostics Market Size for DNA Sequencing and NGs, By Region, 2014–2021 (USD Million)
Table 83 Latin America: Market Size for DNA Sequencing and NGs, By Country, 2014–2021 (USD Million)
Table 84 Molecular Diagnostics Market Size for Microarrays, By Region, 2014–2021 (USD Million)
Table 85 North America: Market Size for Microarrays, By Country, 2014–2021 (USD Million)
Table 86 Europe: Market Size for Microarrays, By Country, 2014–2021 (USD Million)
Table 87 Asia-Pacific: Molecular Diagnostics Market Size for Microarrays, By Country, 2014–2021 (USD Million)
Table 88 RoW: Market Size for Microarrays, By Region, 2014–2021 (USD Million)
Table 89 Latin America: Molecular Diagnostics Market Size for Microarrays, By Country, 2014–2021 (USD Million)
Table 90 Market Size for Other Technologies, By Region, 2014–2021 (USD Million)
Table 91 North America: Market Size for Other Technologies, By Country, 2014–2021 (USD Million)
Table 92 Europe: Molecular Diagnostics Market Size for Other Technologies, By Country, 2014–2021 (USD Million)
Table 93 Asia-Pacific: Market of Molecular Diagnostics: Size for Other Technologies, By Country, 2014–2021 (USD Million)
Table 94 RoW: Molecular Diagnostics Market Size for Other Technologies, By Region, 2014–2021 (USD Million)
Table 95 Latin America: Market Size for Other Technologies, By Country, 2014–2021 (USD Million)
Table 96 Molecular Diagnostics Market Size, By Products & Services, 2014–2021 (USD Million)
Table 97 Molecular Diagnostic Reagents & Kits Market Size, By Region, 2014–2021 (USD Million)
Table 98 North America: Molecular Diagnostic Reagents & Kits Market Size, By Country, 2014–2021 (USD Million)
Table 99 Europe: Molecular Diagnostic Reagents & Kits Market Size, By Country, 2014–2021 (USD Million)
Table 100 Asia-Pacific: Molecular Diagnostic Reagents & Kits Market Size, By Country, 2014–2021 (USD Million)
Table 101 RoW: Molecular Diagnostic Reagents & Kits Market Size, By Region, 2014–2021 (USD Million)
Table 102 Latin America: Molecular Diagnostic Reagents & Kits Market Size, By Country, 2014–2021 (USD Million)
Table 103 Molecular Diagnostic Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 104 North America: Molecular Diagnostic Instruments Market Size, By Country, 2014–2021 (USD Million)
Table 105 Europe: Molecular Diagnostic Instruments Market Size, By Country, 2014–2021 (USD Million)
Table 106 Asia-Pacific: Molecular Diagnostic Instruments Market Size, By Country, 2014–2021 (USD Million)
Table 107 RoW: Molecular Diagnostic Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 108 Latin America: Molecular Diagnostic Instruments Market Size, By Country, 2014–2021 (USD Million)
Table 109 Molecular Diagnostic Software & Services Market Size, By Region, 2014–2021 (USD Million)
Table 110 North America: Molecular Diagnostic Software & Services Market Size, By Country, 2014–2021 (USD Million)
Table 111 Europe: Molecular Diagnostic Software & Services Market Size, By Country, 2014–2021 (USD Million)
Table 112 Asia-Pacific: Molecular Diagnostic Software & Services Market Size, By Country, 2014–2021 (USD Million)
Table 113 RoW: Molecular Diagnostic Software & Services Market Size, By Region, 2014–2021 (USD Million)
Table 114 Latin America: Molecular Diagnostic Software & Services Market Size, By Country, 2014–2021 (USD Million)
Table 115 Molecular Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 116 Market Size for Hospital and Academic Laboratories, By Region, 2014–2021 (USD Million)
Table 117 North America: Market Size for Hospital and Academic Laboratories, By Country, 2014–2021 (USD Million)
Table 118 Europe: Molecular Diagnostics Market Size for Hospital and Academic Laboratories, By Country, 2014–2021 (USD Million)
Table 119 Asia-Pacific: Molecular Diagnostics Market Size for Hospital and Academic Laboratories, By Country, 2014–2021 (USD Million)
Table 120 RoW: Market Size for Hospital and Academic Laboratories, By Region, 2014–2021 (USD Million)
Table 121 Latin America: Molecular Diagnostics Market Size for Hospital and Academic Laboratories, By Country, 2014–2021 (USD Million)
Table 122 Molecular Diagnostics Market Size for Reference Laboratories, By Region, 2014–2021 (USD Million)
Table 123 North America: Market Size for Reference Laboratories, By Country, 2014–2021 (USD Million)
Table 124 Europe: Molecular Diagnostics Market Size for Reference Laboratories, By Country, 2014–2021 (USD Million)
Table 125 Asia-Pacific: Market Size for Reference Laboratories, By Country, 2014–2021 (USD Million)
Table 126 RoW: Molecular Diagnostics Market Size for Reference Laboratories, By Region, 2014–2021 (USD Million)
Table 127 Latin America: Market Size for Reference Laboratories, By Country, 2014–2021 (USD Million)
Table 128 Molecular Diagnostics Market Size for Other End Users, By Region, 2014–2021 (USD Million)
Table 129 North America: Molecular Diagnostics Market Size for Other End Users, By Country, 2014–2021 (USD Million)
Table 130 Europe: Market Size for Other End Users, By Country, 2014–2021 (USD Million)
Table 131 Asia-Pacific: Molecular Diagnostics Market Size for Other End Users, By Country, 2014–2021 (USD Million)
Table 132 RoW: Market Size for Other End Users, By Region, 2014–2021 (USD Million)
Table 133 Latin America: Molecular Diagnostics Market Size for Other End Users, By Country, 2014–2021 (USD Million)
Table 134 Market Size, By Region, 2014–2021 (USD Million)
Table 135 North America: Molecular Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 136 North America: Market Size, By Technology, 2014–2021 (USD Million)
Table 137 North America: Molecular Diagnostics Market Size, By Application, 2014–2021 (USD Million)
Table 138 North America: Market Size, By Product and Service, 2014–2021 (USD Million)
Table 139 North America: Molecular Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 140 U.S.: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 141 U.S.: Market Size, By Application, 2014–2021 (USD Million)
Table 142 U.S.: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 143 U.S.: Market Size, By End User, 2014–2021 (USD Million)
Table 144 Canada: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 145 Canada: Market Size, By Application, 2014–2021 (USD Million)
Table 146 Canada: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 147 Canada: Market Size, By End User, 2014–2021 (USD Million)
Table 148 Europe: Molecular Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 149 Europe: Market Size, By Technology, 2014–2021 (USD Million)
Table 150 Europe: Market Size, By Application, 2014–2021 (USD Million)
Table 151 Europe: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 152 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 153 Germany: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 154 Germany: Market Size, By Application, 2014–2021 (USD Million)
Table 155 Germany: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 156 Germany: Market Size, By End User, 2014–2021 (USD Million)
Table 157 France: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 158 France: Market Size, By Application, 2014–2021 (USD Million)
Table 159 France: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 160 France: Market Size, By End User, 2014–2021 (USD Million)
Table 161 Italy: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 162 Italy: Market Size, By Application, 2014–2021 (USD Million)
Table 163 Italy: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 164 Italy: Market Size, By End User, 2014–2021 (USD Million)
Table 165 Spain: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 166 Spain: Market Size, By Application, 2014–2021 (USD Million)
Table 167 Spain: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 168 Spain: Market Size, By End User, 2014–2021 (USD Million)
Table 169 U.K.: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 170 U.K.: Market Size, By Application, 2014–2021 (USD Million)
Table 171 U.K.: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 172 U.K.: Market Size, By End User, 2014–2021 (USD Million)
Table 173 RoE: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 174 RoE: Market Size, By Application, 2014–2021 (USD Million)
Table 175 RoE: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 176 RoE: Market Size, By End User, 2014–2021 (USD Million)
Table 177 Asia-Pacific: Molecular Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 178 Asia-Pacific: Market Size, By Technology, 2014–2021 (USD Million)
Table 179 Asia-Pacific: Molecular Diagnostics Market Size, By Application, 2014–2021 (USD Million)
Table 180 Asia-Pacific: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 181 Asia-Pacific: Market Size, By End User, 2014–2021 (USD Million)
Table 182 Japan: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 183 Japan: Market Size, By Application, 2014–2021 (USD Million)
Table 184 Japan: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 185 Japan: Market Size, By End User, 2014–2021 (USD Million)
Table 186 China: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 187 China: Market Size, By Application, 2014–2021 (USD Million)
Table 188 China: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 189 China: Market Size, By End User, 2014–2021 (USD Million)
Table 190 Australia: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 191 Australia: Market Size, By Application, 2014–2021 (USD Million)
Table 192 Australia: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 193 Australia: Market Size, By End User, 2014–2021 (USD Million)
Table 194 India: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 195 India: Market Size, By Application, 2014–2021 (USD Million)
Table 196 India: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 197 India: Market Size, By End User, 2014–2021 (USD Million)
Table 198 RoAPAC: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 199 RoAPAC: Market Size, By Application, 2014–2021 (USD Million)
Table 200 RoAPAC: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 201 RoAPAC: Market Size, By End User, 2014–2021 (USD Million)
Table 202 RoW: Molecular Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 203 RoW: Market Size, By Technology, 2014–2021 (USD Million)
Table 204 RoW: Market Size, By Application, 2014–2021 (USD Million)
Table 205 RoW: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 206 RoW: Market Size, By End User, 2014–2021 (USD Million)
Table 207 Latin America: Molecular Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 208 Latin America: Market Size, By Technology, 2014–2021 (USD Million)
Table 209 Latin America: Market Size, By Application, 2014–2021 (USD Million)
Table 210 Latin America: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 211 Latin America: Market Size, By End User, 2014–2021 (USD Million)
Table 212 Brazil: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 213 Brazil: Market Size, By Application, 2014–2021 (USD Million)
Table 214 Brazil: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 215 Brazil: Market Size, By End User, 2014–2021 (USD Million)
Table 216 Mexico: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 217 Mexico: Market Size, By Application, 2014–2021 (USD Million)
Table 218 Mexico: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 219 Mexico: Market Size, By End User, 2014–2021 (USD Million)
Table 220 RoLA: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 221 RoLA: Market Size, By Application, 2014–2021 (USD Million)
Table 222 RoLA: Molecular Diagnostics Market Size, By Product and Service, 2014–2021 (USD Million)
Table 223 RoLA: Market Size, By End User, 2014–2021 (USD Million)
Table 224 Middle East & Africa: Molecular Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 225 Middle East & Africa: MarketSize, By Application, 2014–2021 (USD Million)
Table 226 Middle East & Africa: Market Size, By Product and Service, 2014–2021 (USD Million)
Table 227 Middle East & Africa: Molecular Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 228 New Product Launches and Approvals, 2013–2016
Table 229 Agreements, Collaborations, Partnerships, Joint Ventures, and Contracts, 2013–2016
Table 230 Acquisitions, 2014–2016
Table 231 Other Strategies, 2013–2016


List of Figures (51 Figures)

Figure 1 Research Design
Figure 2 Molecular Diagnostics Market: Top-Down Approach
Figure 3 Molecular Diagnostics Market: Bottom-Up Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Market Data Triangulation Methodology
Figure 6 Molecular Diagnostics Market Snapshot (2016 vs 2021)
Figure 7 Market Size, By Product & Service, 2016 vs 2021
Figure 8 Molecular Diagnostics Market Size, By End User, 2016 vs 2021
Figure 9 Molecular Diagnostics Market Size, By Application, 2016 vs 2021
Figure 10 Market Size, By Technology, 2016 vs 2021
Figure 11 Geographical Snapshot of the Molecular Diagnostics Market
Figure 12 Rising Prevalence of Infectious Diseases & Cancer to Drive Market Growth
Figure 13 MRSA to Be the Fastest-Growing Segment During the Forecast Period
Figure 14 Infectious Diseases Segment to Dominate the Market of Molecular Diagnostics in 2016
Figure 15 Hospitals & Academic Laboratories Will Continue to Dominate the Global Molecular Diagnostics Market in 2021
Figure 16 Reagents & Kits to Grow at the Highest Rate Between 2016 & 2021
Figure 17 Asia-Pacific to Register the Highest CAGR During the Forecast Period
Figure 18 Molecular Diagnostics Market: Drivers, Restraints, Opportunities, and Threats
Figure 19 Growth in the Number of People Living With HIV in 2010 and 2015 (Millions)
Figure 20 Infectious Diseases Segment to Dominate the Molecular Diagnostic Applications Market During the Forecast Period
Figure 21 PCR to Dominate the Molecular Diagnostic Technologies Market During the Forecast Period
Figure 22 Reagents & Kits to Form the Largest Segment of the Molecular Diagnostics Market in 2016
Figure 23 Hospital and Academic Laboratories—The Major End Users of Molecular Diagnostics
Figure 24 Asia-Pacific Will Be the Fastest-Growing Region in the Market
Figure 25 North America Molecular Diagnostics Market Snapshot
Figure 26 Germany, the Dominant Country in the European Molecular Diagnostics Market
Figure 27 Japan Will Continue to Lead the Asia-Pacific Market
Figure 28 Asia-Pacific: Molecular Diagnostics Market Snapshot
Figure 29 Latin America Will Continue to Lead the Asia-Pacific Molecular Diagnostics Market During the Forecast Period
Figure 30 Brazil to Command the Largest Share of the Latin American Molecular Diagnostics Market in 2021
Figure 31 Product Launches and Approvals: Key Strategies Adopted in the Last Three Years
Figure 32 Global Molecular Diagnostics Market Share, By Key Player, 2015
Figure 33 Global Blood Screening Market Share, By Key Player, 2015
Figure 34 Global Microbiology, Key Player Ranking, 2014
Figure 35 Global Market of Molecular Diagnostics: for PCR, Market Share Analysis, By Key Player, 2015
Figure 36 Global Molecular Diagnostics Market for DNA Sequencing and NGs, Market Share Analysis, By Key Player, 2015
Figure 37 Global Molecular Diagnostics Market for Microarray, Market Share Analysis, By Key Player, 2015
Figure 38 Global Market for Hybridization, Key Player Ranking, 2015
Figure 39 Global Market for INAAT, Key Player Ranking, 2015
Figure 40 Battle for Market Share: Product Launches and Approvals Was the Key Growth Strategy
Figure 41 Geographic Revenue Mix of the Top Five Market Players
Figure 42 Abbott Laboratories: Company Snapshot (2015)
Figure 43 Qiagen N.V.: Company Snapshot (2015)
Figure 44 Roche Diagnostics: Company Snapshot (2015)
Figure 45 Hologic, Inc.: Company Snapshot (2015)
Figure 46 Grifols: Company Snapshot (2015)
Figure 47 Siemens Healthcare: Company Snapshot (2016)
Figure 48 Becton, Dickinson and Company: Company Snapshot (2015)
Figure 49 Danaher Corporation: Company Snapshot (2015)
Figure 50 Biomιrieux: Company Snapshot (2015)
Figure 51 Cepheid Inc.: Company Snapshot (2015)

The global molecular diagnostics market is projected to reach USD 10.12 Billion by 2021 from USD 6.54 Billion in 2016, at a CAGR of 9.1% from 2016 to 2021. In this report, the global market is broadly segmented by products & services, application, technology, end user, and region.

High prevalence of infectious diseases and various types of cancer; increasing awareness and acceptance of personalized medicine and companion diagnostics; development of biomarkers; and advancements in molecular techniques, proteomics, and genomics technology research and reformations in the reimbursement system are driving the growth of the market. However, increased cost of molecular diagnostics tools, dearth of skilled labor to handle new and complex platforms, and the complex regulatory framework are the major factors restraining the growth of the market.

The major technologies studied in the report include PCR, INAAT, microarrays, hybridization, DNA sequencing, and Next-generation sequencing (NGS), and other technologies (electrophoresis, flow cytometry, and mass spectrometry). Among these technologies, PCR is expected to command the largest share and microarray segment is expected to be the highest growth segment.

The market of molecular diagnostics, by application, is classified into infectious diseases, oncology, genetics, blood screening, microbiology, and other applications (cardiovascular diseases, neurological diseases, DNA fingerprinting, tissue typing, and food pathogen detection testing). The infectious diseases segment will account for the largest share of the global market in 2016, followed by the blood screening and oncology segments.

On the basis of products & services, the molecular diagnostics market is segmented into instruments, reagents & kits, and services & software. The reagents & kits market is expected to account for the largest share and the highest CAGR of the market in 2016.

The market is segmented into three end-users segments, namely, hospital & academic laboratories, reference laboratories, and others (blood banks, local public health laboratories, home health agencies, nursing homes, point-of-care settings, and self-testing). The hospital & academic laboratories segment is expected to dominate the market because most diagnostic tests are performed in-house. On the other hand, reference laboratories will grow at the fastest pace as newly launched, complex, and highly specialized tests are mostly offered only at a few large reference laboratories.

North America (comprising the U.S. and Canada) is expected to account for the largest share of the global market in 2016, followed by Europe. The largest share of the North American market is majorly driven by the rising prevalence of infectious diseases, availability of government funds, and expansion of the applications of molecular diagnostics in genetic disorders and cancer screening. The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. The high growth in this region can primarily be attributed to the presence of high-growth markets such as China, India, Brazil, Mexico, and South Korea.

Major players operating in the molecular diagnostics market are Roche Diagnostics (U.S.), QIAGEN N.V. (Netherlands), Hologic Inc. (U.S.), Grifols (Spain), Abbott Laboratories (U.S.), Siemens Healthcare (Germany), Becton, Dickinson and Company (U.S.), Beckman Coulter Inc. (U.S.), bioMιrieux SA (France), and Cepheid Inc. (U.S.).

Molecular Diagnostics Market

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth In-Vitro Diagnostics Markets on KnowledgeStore
Request Demo